With
an aging population in the world, it is not surprising that attention
has been placed on the shoulders of Alzheimer's disease , the most
common progressive degenerative disease, it is particularly noteworthy. Alzheimer's
disease causes progressive deterioration of memory and currently
affects one in ten people aged 65 or more, although the current
diagnosis is not perfect, accuracy levels are up to 94 percent more 87 percent at worst . Discovered
in 1906 by German physician Alois Alzheimer , the world's attention on
this disease is only 30 years old , its effects are not known , even
today, with all the research that has been done .
Aging is the main risk of Alzheimer's disease, according to a study . Unfortunately, the person who saw the first symptoms of Alzheimer's disease knows something is wrong, but do not admit to others or to themselves , until that happens, it is difficult to start any type of treatment .
General measures for the treatment of Alzheimer's disease are the same as for all dementias . Unfortunately, because there is still much to learn about the disease, there is no definitive way to treat although some symptoms may improve or slowed down with medication. The top three drugs currently approved for the treatment of Alzheimer's disease are donepezil, tacrine , rivastigmine and because they can improve the mental faculties of patients with this condition for up to 26 weeks.
Memantine is a new drug that slows down in the later stages and is a derivative of decades of struggle against the flu drugs amantadine and this new drug is used in patients with moderate to severe Alzheimer disease already receiving donepezil. Side effects are minimal, but memantine is the first treatment to show a different effect in patients with a serious illness like spending 80 percent of the drug in the urine as unchanged drug is very little not to cause damage.
The average age of a person living in the industrialized world develops is to make Alzheimer's disease a major public health problem to consider, in the United States , is the fourth in the list of deadly diseases. Although the disease is a tragedy , the cost of treatment and care of patients is causing economic vibrations everywhere, with an annual cost of $ 40 billion for care and treatment , patient care is called be a major problem. Nearly half of the annual budget allocated to research on the state last year by the National Institute on Aging , there are currently more than 300 different compounds at various stages of development of their treatment.
To help reduce your risk of developing dementia , it is important to adopt a healthy lifestyle , choose carefully what you eat and drink , and exercise more . In fact , researchers believe that the happier and healthier person with Alzheimer's disease , the slowdown will be their downfall. Fortunately, the early symptoms of this disease are very rare , affecting mainly the elderly, have not yet been recent occasions ( although rare) than a younger person has developed this condition.
Aging is the main risk of Alzheimer's disease, according to a study . Unfortunately, the person who saw the first symptoms of Alzheimer's disease knows something is wrong, but do not admit to others or to themselves , until that happens, it is difficult to start any type of treatment .
General measures for the treatment of Alzheimer's disease are the same as for all dementias . Unfortunately, because there is still much to learn about the disease, there is no definitive way to treat although some symptoms may improve or slowed down with medication. The top three drugs currently approved for the treatment of Alzheimer's disease are donepezil, tacrine , rivastigmine and because they can improve the mental faculties of patients with this condition for up to 26 weeks.
Memantine is a new drug that slows down in the later stages and is a derivative of decades of struggle against the flu drugs amantadine and this new drug is used in patients with moderate to severe Alzheimer disease already receiving donepezil. Side effects are minimal, but memantine is the first treatment to show a different effect in patients with a serious illness like spending 80 percent of the drug in the urine as unchanged drug is very little not to cause damage.
The average age of a person living in the industrialized world develops is to make Alzheimer's disease a major public health problem to consider, in the United States , is the fourth in the list of deadly diseases. Although the disease is a tragedy , the cost of treatment and care of patients is causing economic vibrations everywhere, with an annual cost of $ 40 billion for care and treatment , patient care is called be a major problem. Nearly half of the annual budget allocated to research on the state last year by the National Institute on Aging , there are currently more than 300 different compounds at various stages of development of their treatment.
To help reduce your risk of developing dementia , it is important to adopt a healthy lifestyle , choose carefully what you eat and drink , and exercise more . In fact , researchers believe that the happier and healthier person with Alzheimer's disease , the slowdown will be their downfall. Fortunately, the early symptoms of this disease are very rare , affecting mainly the elderly, have not yet been recent occasions ( although rare) than a younger person has developed this condition.
No comments:
Post a Comment